Home
About
Overview
Sharing Data
ORCID
Help
History (55)
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Evaluating runners with and without anterior knee pain using the time to contact the ankle joint complexes' range of motion boundary.
"The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.
Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control.
Novel Targets of Immunosuppression in Transplantation.
See All 55 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel Targets of Immunosuppression in Transplantation.
Shin HS, Grgic I, Chandraker A. Novel Targets of Immunosuppression in Transplantation. Clin Lab Med. 2019 03; 39(1):157-169.
View in:
PubMed
subject areas
Graft Rejection
Immunologic Factors
Models, Immunological
T-Lymphocytes
Transplantation
Transplantation Conditioning
authors with profiles
Anil Chandraker MD